![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/10 | (2006.01) |
C07D 401/10 | (2013.01) | ||
C07D 211/18 | (2006.01) | ||
C07D 211/18 | (2013.01) |
(11) | Number of the document | 3668857 |
(13) | Kind of document | T |
(96) | European patent application number | 18760237.0 |
Date of filing the European patent application | 2018-08-14 | |
(97) | Date of publication of the European application | 2020-06-24 |
(45) | Date of publication and mention of the grant of the patent | 2023-07-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/046651 |
Date | 2018-08-14 |
(87) | Number | WO 2019/036441 |
Date | 2019-02-21 |
(30) | Number | Date | Country code |
201711028921 | 2017-08-14 | IN | |
201711038212 | 2017-10-27 | IN | |
201811024356 | 2018-06-29 | IN |
(72) |
LUTHRA, Parven, Kumar , IN
VASOYA, Sanjay, Lakhabhai , IN
PATIL, Bhatu, Tumba , IN
TANEJA, Amit, Kumar , IN
SRIVASTAV, Naveen, Chandra , IN
SINGH, Rinku , IN
|
(73) |
Teva Pharmaceuticals International GmbH ,
Schlüsselstrasse 12, 8645 Jona,
CH
|
(54) | PROCESSES FOR THE PREPARATION OF NIRAPARIB AND INTERMEDIATES THEREOF |
PROCESSES FOR THE PREPARATION OF NIRAPARIB AND INTERMEDIATES THEREOF |